Literature DB >> 15241523

[IKOP-Infection control in the operating theatreConsensus on the theme "Barrier measures during operations and invasive procedures"].

B Salzberger1, M Dettenkofer, F M Baer, O Cornely, M Herrmann, J Höher, S Lemmen.   

Abstract

Postoperative surgical site infections remain frequent despite intensive control programs. With rising numbers of operations and invasive procedures in the outpatient setting and in immunocompromised patients, the prevention of wound infections presents a rapidly growing challenge to the medical community. Barrier measures including drapes and surgical gowns to prevent wound contamination, have clearly reduced the rate of wound infections. The optimal material characteristics for operating gowns and drapes are well defined, but there is still a long running controversy on the use of single-use versus reusable materials. We review the efficacy and ecological impacts of these different approaches. Currently no superiority of any of these approaches with regard to either efficacy or ecological impact can be found. The European Union has recently published a series of mandatory standards to specify material characteristics of barrier materials used in operating theatres (EN 13795). Their scope include production standards of these materials as well as specific processes in auditing their characteristics. The implementation of these norms will clearly present a challenge to European hospitals but will lead to better material characteristics in the end.

Entities:  

Mesh:

Year:  2004        PMID: 15241523     DOI: 10.1007/s00101-004-0718-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  47 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

2.  [Surveillance of postoperative wound infections: reference data of the Hospital Infection Surveillance System (KISS)].

Authors:  E Steinbrecher; D Sohr; S Hansen; A Nassauer; F Daschner; H Rüden; P Gastmeier
Journal:  Chirurg       Date:  2002-01       Impact factor: 0.955

3.  Reduction of contamination at total hip replacement by special working clothes.

Authors:  G Blomgren; J Hoborn; B Nyström
Journal:  J Bone Joint Surg Br       Date:  1990-11

4.  Surgical wound infection surveillance: the importance of infections that develop after hospital discharge.

Authors:  D H Mitchell; G Swift; G L Gilbert
Journal:  Aust N Z J Surg       Date:  1999-02

5.  The Second National Prevalence Survey of infection in hospitals--overview of the results.

Authors:  A M Emmerson; J E Enstone; M Griffin; M C Kelsey; E T Smyth
Journal:  J Hosp Infect       Date:  1996-03       Impact factor: 3.926

6.  The role of impervious drapes and gowns preventing surgical infection.

Authors:  P Dineen
Journal:  Clin Orthop Relat Res       Date:  1973-10       Impact factor: 4.176

7.  Survival of patients with surgical wound infection: a case-control study of common surgical interventions.

Authors:  K B Poulsen; C H Wachmann; A Bremmelgaard; A I Sørensen; D Raahave; J V Petersen
Journal:  Br J Surg       Date:  1995-02       Impact factor: 6.939

8.  Ultraclean air and antibiotics for prevention of postoperative infection. A multicenter study of 8,052 joint replacement operations.

Authors:  O M Lidwell; R A Elson; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  Acta Orthop Scand       Date:  1987-02

9.  Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.

Authors:  I I Raad; D C Hohn; B J Gilbreath; N Suleiman; L A Hill; P A Bruso; K Marts; P F Mansfield; G P Bodey
Journal:  Infect Control Hosp Epidemiol       Date:  1994-04       Impact factor: 3.254

10.  The cost of infection in surgical patients: a case-control study.

Authors:  R Coello; H Glenister; J Fereres; C Bartlett; D Leigh; J Sedgwick; E M Cooke
Journal:  J Hosp Infect       Date:  1993-12       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.